These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12969756)

  • 1. Effects of mexiletine on the canine model of sparfloxacin-induced long QT syndrome.
    Takahara A; Sugiyama A; Satoh Y; Hashimoto K
    Eur J Pharmacol; 2003 Aug; 476(1-2):115-22. PubMed ID: 12969756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: potential utility of mexiletine for the treatment of drug-induced long QT syndrome.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn J Pharmacol; 2000 Aug; 83(4):327-34. PubMed ID: 11001179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K
    Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT-prolonging effects of sparfloxacin, a fluoroquinolone antibiotic, assessed in the in vivo canine model with monophasic action potential monitoring.
    Satoh Y; Sugiyama A; Chiba K; Tamura K; Hashimoto K
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):510-5. PubMed ID: 11026654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amitriptyline May Have Possibility to Induce Brugada Syndrome Rather than Long QT Syndrome.
    Lubna NJ; Wada T; Nakamura Y; Chiba K; Cao X; Izumi-Nakaseko H; Ando K; Naito AT; Satoh Y; Sugiyama A
    Cardiovasc Toxicol; 2018 Feb; 18(1):91-98. PubMed ID: 28616803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades.
    Chiba K; Sugiyama A; Satoh Y; Shiina H; Hashimoto K
    Toxicol Appl Pharmacol; 2000 Nov; 169(1):8-16. PubMed ID: 11076691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.
    Bos JM; Crotti L; Rohatgi RK; Castelletti S; Dagradi F; Schwartz PJ; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007280. PubMed ID: 31006312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
    Sugiyama A
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):393-400. PubMed ID: 12835533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome.
    Chiba K; Sugiyama A; Hagiwara T; Takahashi S; Takasuna K; Hashimoto K
    Eur J Pharmacol; 2004 Feb; 486(2):189-200. PubMed ID: 14975708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mexiletine on long QT syndrome model.
    Wang HW; Zheng YQ; Yang ZF; Li CZ; Liu YM
    Acta Pharmacol Sin; 2003 Apr; 24(4):316-20. PubMed ID: 12676070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.
    Crotti L; Neves R; Dagradi F; Musu G; Giannetti F; Bos JM; Barbieri M; Cerea P; Giovenzana FLF; Torchio M; Mura M; Gnecchi M; Conte G; Auricchio A; Sala L; Odening KE; Ackerman MJ; Schwartz PJ
    Circulation; 2024 Aug; 150(7):531-543. PubMed ID: 38939955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
    Kimura K; Tabo M; Mizoguchi K; Kato A; Suzuki M; Itoh Z; Omura S; Takanashi H
    J Toxicol Sci; 2007 Aug; 32(3):231-9. PubMed ID: 17785940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
    Frommeyer G; Garthmann J; Ellermann C; Dechering DG; Kochhäuser S; Reinke F; Köbe J; Wasmer K; Eckardt L
    Europace; 2018 Aug; 20(8):1375-1381. PubMed ID: 29016765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential.
    Satoh Y; Sugiyama A; Tamura K; Hashimoto K
    Jpn Circ J; 2000 Jun; 64(6):445-51. PubMed ID: 10875735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization.
    Yamauchi M; Watanabe E; Yasui K; Takeuchi H; Terasawa T; Sawada K; Hishida H; Kodama I
    Int J Cardiol; 2005 Aug; 103(1):92-7. PubMed ID: 16061129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.
    Liu G; Xue X; Gao C; Huang J; Qi D; Zhang Y; Dong JZ; Ma CS; Yan GX
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mexiletine in the management of long QT syndrome.
    Li G; Zhang L
    J Electrocardiol; 2018; 51(6):1061-1065. PubMed ID: 30497731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antipsychotic and antiemetic drug prochlorperazine delays the ventricular repolarization of the in situ canine heart.
    Satoh Y; Sugiyama A; Takahara A; Ando K; Wang K; Honsho S; Hashimoto K
    J Pharmacol Sci; 2005 Jan; 97(1):101-6. PubMed ID: 15655290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs.
    Motokawa Y; Nakamura Y; Hagiwara-Nagasawa M; Goto A; Chiba K; Lubna NJ; Izumi-Nakaseko H; Ando K; Naito AT; Yamazaki H; Sugiyama A
    Cardiovasc Toxicol; 2018 Jun; 18(3):242-251. PubMed ID: 29139031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.